Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2560
-0.0030 (-1.16%)
Sep 15, 2025, 3:31 PM EDT
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $390.10 million as of September 15, 2025. Its market cap has decreased by -6.81% in one year.
Market Cap
390.10M
Enterprise Value
469.34M
Revenue
1.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.26
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 390.10M, an increase of 3,691.32%. That is a compound annual growth rate of 16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 390.10M | 7.18% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | 1.25B | 870.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 739.21M |
| Elite Pharmaceuticals | 737.49M |
| Glass House Brands | 566.73M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |
| Silence Therapeutics | 230.50M |